Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.65 +0.02 (+1.23%)
As of: Sep 30, 2026 · 3:51 PM EDT

Transcode Therapeutics (RNAZ) Notes Payables (2026)

Updated

Transcode Therapeutics (RNAZ) posted Notes Payables of $652,411 for Q2 2026.

Analysis

Transcode Therapeutics (RNAZ) Notes Payables (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Transcode Therapeutics 1.65 Mn 1.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 652,411.00
API Access

Transcode Therapeutics Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=RNAZ&period=max&api_key=YOUR_API_KEY